ACR Appropriateness Criteria® Management of Uterine Fibroids: 2023 Update

适宜性标准 子宫肌瘤 医学 妇科 放射科
作者
Mina S. Makary,Kylie Zane,Gloria L. Hwang,Charles Kim,Osman Ahmed,Erica M. Knavel Koepsel,Eric J. Monroe,Matthew J. Scheidt,Amanda R. Smolock,Elizabeth A. Stewart,Ashish P. Wasnik,Jason W. Pinchot
出处
期刊:Journal of The American College of Radiology [Elsevier BV]
卷期号:21 (6): S203-S218 被引量:9
标识
DOI:10.1016/j.jacr.2024.02.022
摘要

Uterine fibroids are the most common benign tumor in women of reproductive age and can present with symptoms including bleeding, bulk related symptoms, and infertility. Several treatment options are available for the management of uterine fibroids, including medical management, minimally invasive therapies such as uterine artery embolization and MR-guided focused ultrasound ablation, and surgical interventions ranging from laparoscopic myomectomy to open hysterectomy. Given this wide range of therapeutic interventions, it is important to understand the data supporting these interventions and to be able to apply it in different clinical settings. This document provides a summary of recent trials supporting various therapies for uterine fibroids, including recent evidence for MR-guided focused ultrasound ablation and a detailed discussion of fertility outcomes in myomectomy and uterine fibroid embolization. The American College of Radiology Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed annually by a multidisciplinary expert panel. The guideline development and revision process support the systematic analysis of the medical literature from peer reviewed journals. Established methodology principles such as Grading of Recommendations Assessment, Development, and Evaluation or GRADE are adapted to evaluate the evidence. The RAND/UCLA Appropriateness Method User Manual provides the methodology to determine the appropriateness of imaging and treatment procedures for specific clinical scenarios. In those instances where peer reviewed literature is lacking or equivocal, experts may be the primary evidentiary source available to formulate a recommendation.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Wang_ZiMo发布了新的文献求助10
1秒前
1秒前
2秒前
3秒前
维E真发布了新的文献求助10
3秒前
Hello应助飛666采纳,获得10
4秒前
铁锤发布了新的文献求助10
5秒前
与落发布了新的文献求助10
6秒前
小蓝完成签到 ,获得积分10
7秒前
苍狗完成签到,获得积分10
7秒前
shufessm完成签到,获得积分0
8秒前
9秒前
mix完成签到,获得积分10
9秒前
uppercrusteve完成签到,获得积分10
9秒前
朴实的小土豆完成签到,获得积分10
11秒前
张欢馨应助与落采纳,获得10
14秒前
14秒前
14秒前
机林的海菡完成签到 ,获得积分10
15秒前
16秒前
杜欢发布了新的文献求助10
16秒前
Jasper应助仁爱思天采纳,获得10
17秒前
Wang_ZiMo发布了新的文献求助30
17秒前
创新完成签到,获得积分10
18秒前
molihuakai应助飛666采纳,获得10
18秒前
Orange应助高水平摆烂采纳,获得10
19秒前
创新发布了新的文献求助10
20秒前
香蕉觅云应助英勇的若灵采纳,获得10
21秒前
搁浅完成签到,获得积分10
21秒前
22秒前
23秒前
YK完成签到,获得积分10
25秒前
25秒前
26秒前
领导范儿应助lzzzz采纳,获得10
28秒前
28秒前
YYM发布了新的文献求助10
28秒前
彭于晏应助不易采纳,获得10
29秒前
29秒前
30秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Reducing Compassion Fatigue, Secondary Traumatic Stress and Burnout 600
China Pluperfect I: Epistemology of Past and Outside in Chinese Art 520
Matrix Methods in Data Mining and Pattern Recognition Second Edition 510
Mammalian Synthetic Biology 500
Auslegungsgeschichte 500
Cosmos as Art Object: Studies in Plato's Timaeus and Other Dialogues 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 内科学 物理 复合材料 催化作用 细胞生物学 无机化学 光电子学 物理化学 电极 基因
热门帖子
关注 科研通微信公众号,转发送积分 7638098
求助须知:如何正确求助?哪些是违规求助? 9211411
关于积分的说明 19758652
捐赠科研通 7205015
什么是DOI,文献DOI怎么找? 3275778
关于科研通互助平台的介绍 2437385
邀请新用户注册赠送积分活动 2272954